221 related articles for article (PubMed ID: 32531682)
1. Current scenario of indole derivatives with potential anti-drug-resistant cancer activity.
Jia Y; Wen X; Gong Y; Wang X
Eur J Med Chem; 2020 Aug; 200():112359. PubMed ID: 32531682
[TBL] [Abstract][Full Text] [Related]
2. Recent Development in Indole Derivatives as Anticancer Agents for Breast Cancer.
Kaur K; Jaitak V
Anticancer Agents Med Chem; 2019; 19(8):962-983. PubMed ID: 30864529
[TBL] [Abstract][Full Text] [Related]
3. Indole in the target-based design of anticancer agents: A versatile scaffold with diverse mechanisms.
Dadashpour S; Emami S
Eur J Med Chem; 2018 Apr; 150():9-29. PubMed ID: 29505935
[TBL] [Abstract][Full Text] [Related]
4. Recent advances of podophyllotoxin/epipodophyllotoxin hybrids in anticancer activity, mode of action, and structure-activity relationship: An update (2010-2020).
Xiao J; Gao M; Sun Z; Diao Q; Wang P; Gao F
Eur J Med Chem; 2020 Dec; 208():112830. PubMed ID: 32992133
[TBL] [Abstract][Full Text] [Related]
5. Chalcone Derivatives and their Activities against Drug-resistant Cancers: An Overview.
Xiao J; Gao M; Diao Q; Gao F
Curr Top Med Chem; 2021; 21(5):348-362. PubMed ID: 33092509
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Potential of Indole Derivatives as Anti-HIV Agents: A Mini-review.
Chen Q; Wu C; Zhu J; Li E; Xu Z
Curr Top Med Chem; 2022; 22(12):993-1008. PubMed ID: 34636313
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, in vitro antiproliferative activity and apoptosis-inducing studies of 1-(3',4',5'-trimethoxyphenyl)-3-(2'-alkoxycarbonylindolyl)-2-propen-1-one derivatives obtained by a molecular hybridisation approach.
Preti D; Romagnoli R; Rondanin R; Cacciari B; Hamel E; Balzarini J; Liekens S; Schols D; Estévez-Sarmiento F; Quintana J; Estévez F
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1225-1238. PubMed ID: 30141353
[TBL] [Abstract][Full Text] [Related]
8. Indole Alkaloids, Synthetic Dimers and Hybrids with Potential In Vivo Anticancer Activity.
Song F; Bian Y; Liu J; Li Z; Zhao L; Fang J; Lai Y; Zhou M
Curr Top Med Chem; 2021; 21(5):377-403. PubMed ID: 32901583
[TBL] [Abstract][Full Text] [Related]
9. 3-Aminomethyl derivatives of 4,11-dihydroxynaphtho[2,3-f]indole-5,10-dione for circumvention of anticancer drug resistance.
Shchekotikhin AE; Shtil AA; Luzikov YN; Bobrysheva TV; Buyanov VN; Preobrazhenskaya MN
Bioorg Med Chem; 2005 Mar; 13(6):2285-91. PubMed ID: 15727877
[TBL] [Abstract][Full Text] [Related]
10. Coumarins as Potential Anti-drug Resistant Cancer Agents: A Mini Review.
Wang G; Sun S; Wu B; Liu J
Curr Top Med Chem; 2021; 21(19):1725-1736. PubMed ID: 33185162
[TBL] [Abstract][Full Text] [Related]
11. The importance of indole and azaindole scaffold in the development of antitumor agents.
Han Y; Dong W; Guo Q; Li X; Huang L
Eur J Med Chem; 2020 Oct; 203():112506. PubMed ID: 32688198
[TBL] [Abstract][Full Text] [Related]
12. Indole Derivatives as Anticancer Agents for Breast Cancer Therapy: A Review.
Sidhu JS; Singla R; Mayank ; Jaitak V
Anticancer Agents Med Chem; 2015; 16(2):160-73. PubMed ID: 25991424
[TBL] [Abstract][Full Text] [Related]
13. Indole: A privileged scaffold for the design of anti-cancer agents.
Wan Y; Li Y; Yan C; Yan M; Tang Z
Eur J Med Chem; 2019 Dec; 183():111691. PubMed ID: 31536895
[TBL] [Abstract][Full Text] [Related]
14. 1,2,3-Triazole-containing hybrids as potential anticancer agents: Current developments, action mechanisms and structure-activity relationships.
Xu Z; Zhao SJ; Liu Y
Eur J Med Chem; 2019 Dec; 183():111700. PubMed ID: 31546197
[TBL] [Abstract][Full Text] [Related]
15. Indole/isatin-containing hybrids as potential antibacterial agents.
Song F; Li Z; Bian Y; Huo X; Fang J; Shao L; Zhou M
Arch Pharm (Weinheim); 2020 Oct; 353(10):e2000143. PubMed ID: 32667714
[TBL] [Abstract][Full Text] [Related]
16. Indole-fused azepines and analogues as anticancer lead molecules: Privileged findings and future directions.
Singh AK; Raj V; Saha S
Eur J Med Chem; 2017 Dec; 142():244-265. PubMed ID: 28803677
[TBL] [Abstract][Full Text] [Related]
17. Coumarin-containing hybrids and their anticancer activities.
Zhang L; Xu Z
Eur J Med Chem; 2019 Nov; 181():111587. PubMed ID: 31404864
[TBL] [Abstract][Full Text] [Related]
18. Recent Development in Indole Derivatives as Anticancer Agent: A Mechanistic Approach.
Devi N; Kaur K; Biharee A; Jaitak V
Anticancer Agents Med Chem; 2021; 21(14):1802-1824. PubMed ID: 33397272
[TBL] [Abstract][Full Text] [Related]
19. The current scenario of naturally occurring indole alkaloids with anticancer potential.
Song J; Zhang B; Li M; Zhang J
Fitoterapia; 2023 Mar; 165():105430. PubMed ID: 36634875
[TBL] [Abstract][Full Text] [Related]
20. Anticancer and Reversing Multidrug Resistance Activities of Natural Isoquinoline Alkaloids and their Structure-activity Relationship.
Qing ZX; Huang JL; Yang XY; Liu JH; Cao HL; Xiang F; Cheng P; Zeng JG
Curr Med Chem; 2018; 25(38):5088-5114. PubMed ID: 28933285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]